New York, NY3 Active Studies

Neurofibromatosis Clinical Trials in New York, NY

Find 3 actively recruiting neurofibromatosis clinical trials in New York, NY. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
20,134
Enrolling

Recruiting Neurofibromatosis Studies in New York

About Neurofibromatosis Clinical Trials in New York

Neurofibromatosis is a group of genetic conditions that cause tumors to grow on nerve tissue. NF1 is the most common type, causing skin changes and bone deformities. Treatment includes monitoring, surgery for problematic tumors, and MEK inhibitors for plexiform neurofibromas.

There are currently 3 neurofibromatosis clinical trials recruiting participants in New York, NY. These studies are seeking a combined 20,134 participants. Research is being sponsored by The Children's Tumor Foundation, Scott R. Plotkin, MD, PhD, Healx Limited. Clinical trial participation is free and participants receive study-related medical care at no cost.

Neurofibromatosis Clinical Trials in New York — FAQ

Are there neurofibromatosis clinical trials in New York?

Yes, there are 3 neurofibromatosis clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New York?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.

Are clinical trials in New York free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.

What neurofibromatosis treatments are being tested?

The 3 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for neurofibromatosis.

Data updated October 16, 2026 from ClinicalTrials.gov